Bioventus Inc.(NasdaqGS:BVS) dropped from Russell 3000E Growth Index
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4 USD | +0.76% | -1.72% | -24.10% |
03-13 | Craig-Hallum Adjusts Price Target on Bioventus to $9 From $6, Maintains Buy Rating | MT |
03-12 | Transcript : Bioventus Inc., Q4 2023 Earnings Call, Mar 12, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.10% | 255M | |
+73.17% | 12.38B | |
-15.87% | 8.2B | |
+17.74% | 7.3B | |
+10.58% | 5.32B | |
+33.33% | 4.78B | |
-18.88% | 4.16B | |
-35.55% | 2.43B | |
+2.35% | 2.05B | |
+9.66% | 1.98B |
- Stock Market
- Equities
- BVS Stock
- News Bioventus Inc.
- Bioventus Inc.(NasdaqGS: BVS) dropped from Russell 3000E Growth Index